Evidence map›Paper›PMID 14691479›Full record

ArticleNature immunology2004

Entry is a rate-limiting step for viral infection in a Drosophila melanogaster model of pathogenesis.

Sara Cherry, Norbert Perrimon

Abstract read
In one paragraph

Article in Nature immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Symbiotic Bacteria ModulateInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Vector Specificity of Arbovirus Transmission.Frontiers in microbiology · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Decreased function of survival motor neuron protein impairs endocytic pathways.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sara CherryDepartment of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA. scherry@genetics.med.harvard.edu
Norbert Perrimon
Howard Hughes Medical Institute · USPediatrics and Genetics · US

Funding

Viral Immunity in DrosophilaR01AI051365 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI PERRIMON, NORBERT · 2003 to 2007
$1.7M
NIAID NIH HHS R01 AI051365NIAID NIH HHS R01-AI51365-01A1
6 · The paper itself

Abstract

The identification of host factors that control susceptibility to infection has been hampered by a lack of amenable genetic systems. We established an in vivo model to determine the host factors that control pathogenesis and identified viral entry as a rate-limiting step for infection. We infected Drosophila melanogaster cells and adults with drosophila C virus and found that the clathrin-mediated endocytotic pathway is essential for both infection and pathogenesis. Heterozygosity for mutations in genes involved in endocytosis is sufficient to protect flies from pathogenicity, indicating the exquisite sensitivity and dependency of the virus on this pathway. Thus, this virus model provides a sensitive and efficient approach for identifying components required for pathogenesis.

Indexed as

AnimalsBlotting, WesternCell LineClathrinCytopathogenic Effect, ViralDisease Models, AnimalDrosophila melanogasterDynaminsEndocytosisInsect VirusesMicroscopy, FluorescencePicornaviridaePicornaviridae InfectionsClathrinDynamins

Identifiers

PMID14691479
PMCPMC6373454
OpenAlexW1988723707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.